This discrepancy may be attributed to varying expression levels of AGK protein in these two cell lines (Figure S1B) or could be associated with the heightened activation of the PI3K/AKT/mTOR signaling pathway in triple-negative breast cancer [30,31]. The gene discussed is AKT1; the disease is triple-negative breast carcinoma.